SB 431542

Grouped product items
Size	Price	Qty
1mg	$20.00
10mg	$120.00

Catalog Number : 3014193

description

SB 431542 is a selective inhibitor of the TGF-beta type I receptor activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7 to the exclusion of the BMP type I receptors ALK2, ALK3, and ALK6. It is reported to be useful in promoting stem cell differentiation by suppressing cell renewal by blocking Smad signaling.

Additional Information

Applications:	FA
Synonyms:	SB-431542, CHEMBL440084, 3tzm, GTPL8216, FHYUGAJXYORMHI-UHFFFAOYSA-N
Formulation:	Crystalline solid
Chemical Name:	4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide
Molecular Formula:	C₂₂H₁₆N₄O₃
Molecular Weight:	384.4
CAS Number	301836-41-9
Purity:	≥98%
Storage Conditions:	Product should be kept at -20°C.
References:	Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., ... & Hill, C. S. (2002). SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Molecular pharmacology, 62(1), 65-74. Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., ... & Olson, B. A. (2002). Inhibition of transforming growth factor (TGF)-β1–induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Molecular pharmacology, 62(1), 58-64. Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005). A specific inhibitor of TGF-β receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia, 7(5), 509-521.